Literature DB >> 3882501

Anti-islet cellular and humoral immunity, T-cell subsets, and thymic function in type I diabetes.

M C Quiniou-Debrie, M Debray-Sachs, M Dardenne, P Czernichow, R Assan, J F Bach.   

Abstract

UNLABELLED: Peripheral lymphocyte subsets were enumerated, using OKT monoclonal sera, in 56 diabetic (43 adults and 13 children) and 20 control subjects. Concomitantly, anti-islet humoral and cellular immunity was tested in vitro and serum thymulin level was measured. In the newly diagnosed patients (less than 30 days; 18 cases), the percent of OKT4+ and OKT8+ cells was reduced, the OKT8+ depletion being particularly pronounced in children. Tests for cellular immunity were positive in 83% of the newly diagnosed diabetic subjects and anti-islet cytotoxic antibodies were detected in 50%. The serum thymulin level was decreased in 2 children. Later on in the course of the disease, a marked reduction in OKT3+, OKT4+, and OKT8+ cell percentage was observed, the mean OKT4/OKT8 ratio being normal or lower than normal. The percent of antibody-positive sera rose to 64%, while anti-islet cellular immunity was detectable in 54%. When extrapancreatic manifestations of probable autoimmune nature were present, anti-islet cellular immunity was detected in 100% of cases, accompanied by cytotoxic antibodies in 54%.
CONCLUSIONS: (1) the magnitude of T-cell depletion and/or imbalance in diabetic subjects depended mainly on the duration of the disease, (2) anti-islet cellular immunity was the anomaly most frequently detectable, and (3) a decrease in serum thymulin level was infrequently detected.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882501     DOI: 10.2337/diab.34.4.373

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

Authors:  M P Nair; E W Lewis; S A Schwartz
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

Review 2.  Mechanisms of autoimmunity in insulin-dependent diabetes mellitus.

Authors:  J F Bach
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

3.  Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes.

Authors:  J Ilonen; H M Surcel; M L Käär
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

4.  Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives.

Authors:  M Peakman; T Warnock; A Vats; G L McNab; J Underhill; P T Donaldson; D Vergani
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

5.  Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus.

Authors:  R J Diepersloot; K P Bouter; W E Beyer; J B Hoekstra; N Masurel
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

6.  Cell-mediated autoimmunity at the onset of insulin-dependent diabetes mellitus (IDDM).

Authors:  A G Ziegler; E Standl; T Lander; C Nerl; E P Rieber; H Mehnert
Journal:  Klin Wochenschr       Date:  1987-07-15

7.  The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+.

Authors:  P De Berardinis; M Londei; M Kahan; F Balsano; S Kontiainen; E A Gale; G F Bottazzo; M Feldmann
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.